Javier Munoz, MD, MS, FACP
Advertisement
Articles by Javier Munoz, MD, MS, FACP
Javier Munoz, MD, MS, FACP, of the Mayo Clinic, considers the appropriateness for CAR T-cell therapy for a 66-year-old woman with relapsed/refractory mantle cell lymphoma.
Advertisement
Latest Updated Articles
Mantle Cell Lymphoma: Overview and Standard of CarePublished: August 28th 2020 | Updated:
R/R MCL: Treating With CAR-TPublished: August 28th 2020 | Updated:
Rationale for CAR-T to Treat R/R MCLPublished: August 28th 2020 | Updated:
Case Overview: 66-Year-Old Woman With MCLPublished: August 28th 2020 | Updated:
Next Steps in Research in R/R MCLPublished: August 28th 2020 | Updated:
R/R MCL: Applying Data Into Clinical PracticePublished: August 28th 2020 | Updated:
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
Gedatolisib Improves PFS in HR+/HER2-/PIK3CA-WT Advanced Breast Cancer
2
Nadunolimab Misses Efficacy Mark in TNBC, Despite Strong OS
3
FDA Approves Niraparib/Abiraterone Combo for BRCA2-Mutated mCSPC
4
Giredestrant/Everolimus Improves PFS Across Subgroups After CDK4/6i in ER+/HER2– Breast Cancer
5
